HomeMCRB • NASDAQ
add
Seres Therapeutics Inc
Previous close
$0.97
Day range
$0.98 - $1.07
Year range
$0.54 - $6.26
Market cap
151.04M USD
Avg Volume
5.05M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 17.88M | -31.42% |
Net income | -40.13M | 43.61% |
Net profit margin | — | — |
Earnings per share | -0.27 | 52.63% |
EBITDA | -38.03M | 45.02% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 111.18M | 4.36% |
Total assets | 341.26M | 26.30% |
Total liabilities | 401.00M | 26.07% |
Total equity | -59.74M | — |
Shares outstanding | 151.45M | — |
Price to book | -2.50 | — |
Return on assets | -28.28% | — |
Return on capital | -61.18% | — |
Cash Flow
Net change in cash
(USD) | Mar 2024info | Y/Y change |
---|---|---|
Net income | -40.13M | 43.61% |
Cash from operations | -35.24M | 53.99% |
Cash from investing | -62.00K | -102.26% |
Cash from financing | 18.76M | 231.72% |
Net change in cash | -16.54M | 75.75% |
Free cash flow | -28.09M | 52.84% |
About
CEO
Founded
2010
Website
Employees
233